Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Latin America and the Caribbean (LAC) maintained high childhood vaccination coverage for 17 years but faced setbacks, increasing vulnerability to vaccine-preventable diseases. Despite signs of recovery, geographic inequalities and social deprivations persist. This study provides an up-to-date cross-sectional analysis of prevalence, subnational variation, and key determinants of suboptimal basic child vaccination (BCV).

Methods: We produced weighted estimates of suboptimal BCV prevalence at the national and subnational levels via harmonized data from household surveys spanning a 12-year period (2011-2022) in the LAC region. Six BCV-related outcomes were analysed: completely unvaccinated, no BCG, no DTP, no OPV, no MCV and not fully vaccinated. We employed a four-level mixed-effects logistic regression to analyse determinants of suboptimal BCV and to partition the total outcome variation over country, region, primary sample units (PSUs) and child‒mother‒household levels. Choropleth maps were used to illustrate the weighted mean prevalence of subnational regions for each outcome. Additionally, sensitivity analyses were performed to validate the findings and assess robustness.

Findings: A total of 18,136 children aged 12-23 months across 211 subnational regions in 15 LAC countries were analysed. The prevalence of suboptimal BCV ranged from 0.99% completely unvaccinated to 66% not fully vaccinated. Significant subnational disparities were observed: while all subnational regions in Cuba and Costa Rica had consistently low rates of completely unvaccinated children (< 3%), subnational regions or states such as Upper Takutu-Upper Essequibo and Mahaica-Berbice (Guyana) reported much higher rates, reaching 30.23% (95% CI: 9.52-50.94) and 26.56% (95% CI: 11.39-41.73), respectively. Maternal deprivation increased the risk of suboptimal BCV. The prevalence of completely unvaccinated children was significantly greater among those whose mothers did not have institutional delivery (3.35%; 95% CI: 3.07-3.63) than among those whose mothers had institutional delivery (0.74%; 95% CI: 0.70-0.79). The likelihood of suboptimal BCV outcomes increased as health services and socioeconomic deprivation intensified and intersected.

Conclusions: In LACs, geographic inequalities and multiple deprivations increase the risk of suboptimal BCV. These countries should prioritize efforts to vaccinate children whose mothers lack access to one or more key health services, especially those from poor families.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183808PMC
http://dx.doi.org/10.1186/s12939-025-02561-9DOI Listing

Publication Analysis

Top Keywords

suboptimal bcv
12
completely unvaccinated
12
subnational regions
12
suboptimal basic
8
basic child
8
child vaccination
8
latin america
8
america caribbean
8
cross-sectional analysis
8
18136 children
8

Similar Publications

Background: Latin America and the Caribbean (LAC) maintained high childhood vaccination coverage for 17 years but faced setbacks, increasing vulnerability to vaccine-preventable diseases. Despite signs of recovery, geographic inequalities and social deprivations persist. This study provides an up-to-date cross-sectional analysis of prevalence, subnational variation, and key determinants of suboptimal basic child vaccination (BCV).

View Article and Find Full Text PDF

One kind of autonomous vehicle that can take instructions from the driver by reading their electroencephalogram (EEG) signals using a Brain-Computer Interface (BCI) is called a Brain-Controlled Vehicle (BCV). The operation of such a vehicle is greatly affected by how well the BCI works. At present, there are limitations on the accuracy of BCI recognition, the number of distinguishable command categories, and the execution duration of command recognition.

View Article and Find Full Text PDF

Smallpox, caused by (VARV), was eradicated in 1980; however, VARV bioterrorist threats still exist, necessitating readily available therapeutics. Current preparedness activities recognize the importance of oral antivirals and recommend therapeutics with different mechanisms of action. (MPXV) is closely related to VARV, causing a highly similar clinical human disease, and can be used as a surrogate for smallpox antiviral testing.

View Article and Find Full Text PDF